National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 8) (PB 79 of 2017) (Cth)

Case

PB 79 of 2017

National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 8)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated       28   September 2017

LISA LA RANCE

Assistant Secretary

Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health

Part 1         Preliminary

  1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2017 (No. 8).

(2)   This Determination may also be cited as PB 79 of 2017.

  1. Commencement

This Determination commences on 1 October 2017.

  1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Amino acid formula with vitamins and minerals and long chain polyunsaturated fatty acids without phenylalanine

Insert

Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid

[2]     Schedule 1, after item dealing with Bevacizumab

Omit

Bimatoprost

[3]     Schedule 1, after item dealing with Brentuximab vedotin

Insert

Brexpiprazole

[4]     Schedule 1, after item dealing with Fosamprenavir

Insert

Fosaprepitant

[5]     Schedule 1, after item dealing with Glucose and ketone indicator urine

Omit

Glucose indicator - blood

[6]     Schedule 1, after item dealing with Glycomacropeptide and essential amino acids with vitamins and minerals

Omit

Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine

[7]     Schedule 1, after item dealing with Ibandronic acid

Omit

Ibuprofen

[8]     Schedule 1, after item dealing with Propylthiouracil

Omit

Protein formula with amino acids, carbohydrates, vitamins and minerals without phenylalanine, and supplemented with docasahexaenoic acid

Insert

Protein formula with amino acids, carbohydrates, vitamins and minerals without phenylalanine, and supplemented with docosahexaenoic acid

[9]     Schedule 1, after item dealing with Sterculia with frangula bark

Omit

Strontium

[10]   Schedule 2, after item dealing with Bicalutamide

Insert

Bimatoprost

[11]   Schedule 2, after item dealing with Cabergoline

Insert

Calcipotriol with betamethasone

[12]   Schedule 2, after item dealing with Hypromellose with dextran

Insert

Ibuprofen

[13]   Schedule 2, after item dealing with Minocycline

Insert

Mirtazapine

Omit

Misoprostol

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0